How much is Inhibrx worth in 2026?

Inhibrx has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Inhibrx raised?

Inhibrx has raised N/A in total funding across 2 funding rounds.

Inhibrx

Drug Discovery

Inhibrx valuation and funding history | Last updated: August 31, 2023 | 2 funding rounds

Current Valuation

N/A

As of August 31, 2023

Total Funding Raised

N/A

Across 2 rounds

Last Round

PIPE

$200.0M

Last Funding

Aug 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 31, 2023	PIPE	$200.0M	N/A	-
April 15, 2020	Later Stage VC	$55.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Inhibrx is currently valued at N/A as of August 31, 2023.

Track Inhibrx Valuation Updates

Get notified when Inhibrx raises new funding or valuation changes

Explore More Data

Detailed analysis for Inhibrx

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Inhibrx's valuation history, funding rounds, and growth metrics.

No credit card required

What is Inhibrx Worth in 2026?

Inhibrx is a leading private company in the Drug Discovery sector. Track Inhibrx's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Inhibrx Valuation is Determined

Private company valuations like Inhibrx's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.